Brian Pollack MD/PhD
Academic Appointment
- Assistant Professor, Department of Dermatology, Emory University School of Medicine
Education
Degrees
- BA from Rutgers University
- PhD from Graduate School of Biomedical Sciences-University of Medicine and Dentistry of New Jersey
- MD from Robert Wood Johnson Medical School-University of Medicine and Dentistry of New Jersey
Research
Focus
- Our laboratory is interested in understanding how oncogenic signal transduction impacts the expression of immune system genes. Specifically, we are interested in how activation of the epidermal growth factor receptor impacts the expression of MHC class I and class II molecules. Further, we are also interested in defining in vivo how inhibitors of oncogenic kinases influence T cell mediated immune responses.
Publications
-
Correction: Epidermal growth factor dampens pro-inflammatory gene expression induced by interferon-gamma in global transcriptome analysis of keratinocytes.
BMC Genomics Volume: 26 Page(s): 291
03/24/2025 Authors: Gibbs DC; McCrary MR; Moreno CS; Seldin L; Li C; Kamili NAH; Pollack BP -
Epidermal growth factor dampens pro-inflammatory gene expression induced by interferon-gamma in global transcriptome analysis of keratinocytes.
BMC Genomics Volume: 26 Page(s): 122
02/10/2025 Authors: Gibbs DC; McCrary MR; Moreno CS; Seldin L; Li C; Kamili NAH; Pollack BP -
Corrigendum to "Sustained release hydrogel for durable locoregional chemoimmunotherapy for BRAF-mutated melanoma" [Journal of Controlled Release 357 (2023) 655-668].
J Control Release Volume: 366 Page(s): 834 - 837
02/01/2024 Authors: Kim J; Archer PA; Manspeaker MP; Avecilla ARC; Pollack BP; Thomas SN -
Obesity-induced dysregulation of skin-resident PPAR+ Treg cells promotes IL-17A-mediated psoriatic inflammation.
Immunity Volume: 56 Page(s): 1844 - 1861.e6
08/08/2023 Authors: Sivasami P; Elkins C; Diaz-Saldana PP; Goss K; Peng A; Hamersky M; Bae J; Xu M; Pollack BP; Horwitz EM -
Sustained release hydrogel for durable locoregional chemoimmunotherapy for BRAF-mutated melanoma.
J Control Release Volume: 357 Page(s): 655 - 668
05/01/2023 Authors: Kim J; Archer PA; Manspeaker MP; Avecilla ARC; Pollack BP; Thomas SN -
Characteristics of the dermatologic cases on a popular crowdsourcing platform.
J Am Acad Dermatol Volume: 88 Page(s): 164 - 165
01/01/2023 Authors: McCrary MR; Wu A; Pollack BP -
Transcriptional profiling of cutaneous immunotoxicity from melanoma immunotherapy
Volume: 142 Page(s): S5 - S5
08/01/2022 Authors: Chang DY; Claussen H; Pollack B; Yeung H; Chen SC; Feldman R; Cole E -
Cutaneous findings in myotonic dystrophy.
JAAD Int Volume: 7 Page(s): 7 - 12
06/01/2022 Authors: Kong HE; Pollack BP -
Cannabinoids in dermatologic surgery.
J Am Acad Dermatol Volume: 85 Page(s): 1565 - 1570
12/01/2021 Authors: Kong HE; Pollack BP; Blalock TW -
Epidermal growth factor modifies immune gene expression in keratinocytes and Melanoma
Volume: 141 Page(s): B8 - B8
09/01/2021 Authors: Gibbs DC; McCrary MR; Moreno CS; Pollack BP